Search

everythinglearnresearchcommunity

for

Search:↓

Policosanol helps treat hair loss by balancing hormones and supporting hair growth.

Minoxidil, a common hair loss treatment, might work by counteracting a hormone that reduces hair growth and promotes hair loss.

Testosterone use for muscle growth can cause hair loss in males.

Low testosterone may increase COVID-19 severity in men.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.

Dendrobium officinale polysaccharide helps hair regrowth in hair loss mice by affecting local steroid metabolism and hair follicle responses.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

CBD may help restore hair growth-related protein levels in alopecia caused by hormones or other factors.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Androgens help motor neurons grow by increasing neuritin.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Stopping finasteride improved sperm counts in two men, reducing the need for fertility treatments.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Androgens cause oil-producing skin cells with androgen receptors to mature and produce more oil.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.